BioWorld-International-2005-10-05
Scientists Probe Signature' Of Cancer Genetic Damage
Karo Bio Seeking SEK280M In Discounted Rights Issue
Karo Bio AB is seeking SEK280 million (US$35.9 million) in a discounted rights issue to fund its switch from early stage discovery to clinical development. (BioWorld International)

